| |
| |
|
| Insider
Information: |
Steiner Mitchell Shuster |
| Relationship: |
President and CEO, Dir... |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,072,631 |
|
|
Indirect Shares
|
2,687,445 |
|
|
| Direct
Value |
$7,741,847 |
|
|
|
Indirect Value
|
$1,016,824 |
|
|
| Total
Shares |
11,760,076 |
|
|
| Total
Value |
$8,758,672 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-8.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -230.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
Chief Executive Office... |
2012-07-16 |
2,129,922 |
2012-07-16 |
2,543,445 |
Premium* |
|
|
Veru Inc |
VERU |
President and CEO, Dir... |
2024-05-24 |
6,942,709 |
2024-05-24 |
144,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2008-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,037,631 |
2,064,131 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2008-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,037,632 |
2,064,132 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2008-09-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,075,263) |
0 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-01-27 |
4 |
B |
$10.54 |
$17,918 |
I/I |
1,700 |
1,700 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-01-28 |
4 |
B |
$10.53 |
$17,901 |
I/I |
1,700 |
3,400 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-01-29 |
4 |
B |
$10.64 |
$18,088 |
I/I |
1,700 |
5,100 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2009-11-10 |
4 |
B |
$3.73 |
$8,579 |
I/I |
2,300 |
133,741 |
2.56 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2010-01-29 |
4 |
GA |
$0.00 |
$0 |
D/D |
171,990 |
2,236,122 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2010-01-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
171,990 |
28,010 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2010-01-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
300,000 |
300,000 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2010-01-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
300,000 |
1,936,122 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-04-09 |
4 |
S |
$3.66 |
$142,264 |
I/I |
(38,923) |
2,025,208 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-04-10 |
4 |
S |
$3.59 |
$16,160 |
I/I |
(4,500) |
2,020,708 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-04-11 |
4 |
S |
$3.51 |
$93,313 |
I/I |
(26,585) |
1,994,123 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-04-12 |
4 |
S |
$3.50 |
$3,980 |
I/I |
(1,137) |
1,992,986 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-07-12 |
4 |
S |
$3.70 |
$142,683 |
I/I |
(38,563) |
1,954,423 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-07-13 |
4 |
S |
$3.76 |
$230,942 |
I/I |
(61,437) |
1,892,986 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Executive Officer |
• • • |
2012-07-16 |
4 |
S |
$3.67 |
$91,778 |
I/I |
(25,035) |
1,867,951 |
0 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2017-06-09 |
4 |
B |
$1.28 |
$51,220 |
I/I |
40,000 |
40,000 |
2.64 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2017-06-12 |
4 |
B |
$1.26 |
$18,897 |
I/I |
15,000 |
55,000 |
2.56 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2017-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,058,640 |
7,704,142 |
0 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2017-08-30 |
4 |
B |
$1.66 |
$9,313 |
D/D |
5,625 |
7,764,767 |
3.15 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2017-09-14 |
4 |
B |
$1.54 |
$35,632 |
I/I |
23,103 |
5,758 |
2.64 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2017-09-15 |
4 |
B |
$1.66 |
$127,703 |
I/I |
76,897 |
25,000 |
2.64 |
- |
|
| VERU |
Veru Inc |
President and CEO |
• • • |
2018-03-06 |
4 |
B |
$1.50 |
$29,996 |
I/I |
20,000 |
30,000 |
2.64 |
- |
|
148 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
